These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19913051)

  • 1. Inhibitory receptors on myeloid cells: new targets for therapy?
    Munitz A
    Pharmacol Ther; 2010 Jan; 125(1):128-37. PubMed ID: 19913051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of allergic inflammatory responses by inhibitory receptors.
    Shik D; Munitz A
    Clin Exp Allergy; 2010 May; 40(5):700-9. PubMed ID: 20447082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-type lectin-like receptors on myeloid cells.
    Pyz E; Marshall AS; Gordon S; Brown GD
    Ann Med; 2006; 38(4):242-51. PubMed ID: 16754255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell signaling pathways.
    Vivier E; Nunès JA; Vély F
    Science; 2004 Nov; 306(5701):1517-9. PubMed ID: 15567854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung dendritic cells: targets for therapy in allergic disease.
    Lambrecht BN; Hammad H
    Handb Exp Pharmacol; 2009; (188):99-114. PubMed ID: 19031023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells.
    Platzer B; Richter S; Kneidinger D; Waltenberger D; Woisetschläger M; Strobl H
    J Immunol; 2009 Jul; 183(1):66-74. PubMed ID: 19535631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activating and inhibitory signaling in mast cells: new opportunities for therapeutic intervention?
    Ott VL; Cambier JC
    J Allergy Clin Immunol; 2000 Sep; 106(3):429-40. PubMed ID: 10984360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imbalance of NKG2D and its inhibitory counterparts: how does tumor escape from innate immunity?
    Zhang C; Zhang J; Wei H; Tian Z
    Int Immunopharmacol; 2005 Jul; 5(7-8):1099-111. PubMed ID: 15914316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immunity: cells, receptors, and signaling pathways.
    Błach-Olszewska Z
    Arch Immunol Ther Exp (Warsz); 2005; 53(3):245-53. PubMed ID: 15995585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.
    Takahashi K; Prinz M; Stagi M; Chechneva O; Neumann H
    PLoS Med; 2007 Apr; 4(4):e124. PubMed ID: 17425404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors.
    Ortaldo JR; Winkler-Pickett R; Willette-Brown J; Wange RL; Anderson SK; Palumbo GJ; Mason LH; McVicar DW
    J Immunol; 1999 Nov; 163(10):5269-77. PubMed ID: 10553049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagen-mediated survival signaling is modulated by CD45 in Jurkat T cells.
    Bijian K; Zhang L; Shen SH
    Mol Immunol; 2007 Jul; 44(15):3682-90. PubMed ID: 17524482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergy, Allergic Inflammation and Asthma--Keystone Symposium. Pharmacological targets in allergic inflammation and asthma.
    Kierstein S
    IDrugs; 2006 Jun; 9(6):405-8. PubMed ID: 16752308
    [No Abstract]   [Full Text] [Related]  

  • 14. Interleukin 1 and tumor necrosis factor signal transduction mechanisms: potential targets for pharmacological control of inflammation.
    Saklatvala J; Guesdon F
    J Rheumatol Suppl; 1992 Jan; 32():65-9; discussion 69-70. PubMed ID: 1319489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses.
    Colonna M; Facchetti F
    J Infect Dis; 2003 Jun; 187 Suppl 2():S397-401. PubMed ID: 12792857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular signaling by the killer immunoglobulin-like receptors and Ly49.
    McVicar DW; Burshtyn DN
    Sci STKE; 2001 Mar; 2001(75):re1. PubMed ID: 11752646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NKG2D receptor: sensing stressed cells.
    López-Larrea C; Suárez-Alvarez B; López-Soto A; López-Vázquez A; Gonzalez S
    Trends Mol Med; 2008 Apr; 14(4):179-89. PubMed ID: 18353724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders.
    Goldman M
    Clin Exp Immunol; 2007 Feb; 147(2):208-16. PubMed ID: 17223960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors.
    Hara H; Ishihara C; Takeuchi A; Imanishi T; Xue L; Morris SW; Inui M; Takai T; Shibuya A; Saijo S; Iwakura Y; Ohno N; Koseki H; Yoshida H; Penninger JM; Saito T
    Nat Immunol; 2007 Jun; 8(6):619-29. PubMed ID: 17486093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of various immune modulatory molecules in CD34(+) hematopoietic cells.
    Umland O; Heine H; Miehe M; Marienfeld K; Staubach KH; Ulmer AJ
    J Leukoc Biol; 2004 Apr; 75(4):671-9. PubMed ID: 14742640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.